Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exosomes as smart drug delivery vehicles for cancer immunotherapy
Huan Zhang, Simiao Wang, Man Sun, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Inseong Jung, Sanghee Shin, Moon‐Chang Baek, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 19-31
Open Access | Times Cited: 46
Recent advances and clinical translation of liposomal delivery systems in cancer therapy
Jiayi Chen, Siyuan Hu, Man Sun, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 193, pp. 106688-106688
Open Access | Times Cited: 45
Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application
Qian Yang, Shisheng Li, Haibo Ou, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 42
Exosomal circRNAs: Novel biomarkers and therapeutic targets for urinary tumors
Qiang Liu, Shenglong Li
Cancer Letters (2024) Vol. 588, pp. 216759-216759
Closed Access | Times Cited: 22
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Amirata Mohseni, Fatemeh Salehi, Samaneh Rostami, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Delving Into Nanoparticle Systems for Enhanced Drug Delivery Technologies
Nimra Abaidullah, Khalid Muhammad, Yasir Waheed
AAPS PharmSciTech (2025) Vol. 26, Iss. 3
Closed Access | Times Cited: 2
Reigniting hope in cancer treatment: the promise and pitfalls of IL-2 and IL-2R targeting strategies
Shan Muhammad, Tao Fan, Yang Hai, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 41
Exosomes in brain diseases: Pathogenesis and therapeutic targets
Qingying Si, Linlin Wu, Deshui Pang, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 31
Digging the intercellular crosstalk via extracellular vesicles: May exosomes be the drug delivery solution for target glioblastoma?
Ana Helena MAcedo-Pereira, Cláudia Martins, Jorge Lima, et al.
Journal of Controlled Release (2023) Vol. 358, pp. 98-115
Open Access | Times Cited: 27
Extracellular Vesicles: A New Star for Gene Drug Delivery
Man Sun, Huan Zhang, Jiayi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2241-2264
Open Access | Times Cited: 12
Advances in exosomes utilization for clinical applications in cancer
Inês A. Batista, José Carlos Machado, Sónia A. Melo
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 947-968
Closed Access | Times Cited: 9
Lyophilized Small Extracellular Vesicles (sEVs) Derived from Human Adipose Stem Cells Maintain Efficacy to Promote Healing in Neuronal Injuries
Brianna M. Jones, Rekha Patel, Bangmei Wang, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 275-275
Open Access | Times Cited: 1
Immunotherapy: cancer immunotherapy and its combination with nanomaterials and other therapies
Yuanyuan Guo, Fengyuan Gao, Adeel Ahmed, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 36, pp. 8586-8604
Closed Access | Times Cited: 19
Current progress, strategy, and prospects of PD-1/PDL-1 immune checkpoint biosensing platforms for cancer diagnostics, therapy monitoring, and drug screening
Katarzyna Ratajczak, Hubert Grel, Piotr Olejnik, et al.
Biosensors and Bioelectronics (2023) Vol. 240, pp. 115644-115644
Open Access | Times Cited: 18
Exosomes as new generation vehicles for drug delivery systems
Nihat Dilsiz
Journal of Drug Delivery Science and Technology (2024) Vol. 95, pp. 105562-105562
Closed Access | Times Cited: 7
Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy
Salima Shebbo, Najat Binothman, Manar Darwaish, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Extracellular vesicles for breast cancer diagnosis and therapy
Jianan Shi, Huan Zhang, Yaxin Cui, et al.
Extracellular Vesicle (2024) Vol. 3, pp. 100039-100039
Open Access | Times Cited: 7
Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists
Theia Minev, Shani Balbuena, Jaya M. Gill, et al.
Oncotarget (2024) Vol. 15, Iss. 1, pp. 793-805
Open Access | Times Cited: 7
Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance
Shikshya S. Panda, Rajeev Kumar Sahoo, Sambit K. Patra, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104061-104061
Closed Access | Times Cited: 6
Exosome-based immunotherapy as an innovative therapeutic approach in melanoma
Shabnam Babaei, Manouchehr Fadaee, Hajar Abbasi‐Kenarsari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Dendritic cell-derived exosomes (Dex): Underlying the role of exosomes derived from diverse DC subtypes in cancer pathogenesis
Gulixian Tuluwengjiang, Irodakhon Rasulova, Shamim Ahmed, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155097-155097
Closed Access | Times Cited: 5
Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art
Hamid Heydari Sheikh Hossein, Francesca Iommelli, Natalia Di Pietro, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 519-519
Open Access | Times Cited: 5
Exosomes target HBV-host interactions to remodel the hepatic immune microenvironment
Xiaojing Wu, Junqi Niu, Ying Shi
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Current Trends and Innovative Approaches in Cancer Immunotherapy
Jae-Chang Kim, Ruby Maharjan, Jonghyuck Park
AAPS PharmSciTech (2024) Vol. 25, Iss. 6
Closed Access | Times Cited: 4
Extracellular Vesicles in Ovarian Cancer: From Chemoresistance Mediators to Therapeutic Vectors
Muttiah Barathan, Nur Dina Muhammad Fuad, Faizul Jaafar, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1806-1806
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top